4507.T
Shionogi & Co.,Ltd.
プライム · 医薬品 · 医薬品 · JP
JPY 2,992.00
+0.34%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 499.7B | 499.7B | 438.3B | 435.1B | 426.7B |
| Cost of Revenue | 12.3B | 82.5B | 63.8B | — | 62.2B |
| Gross Profit | 87.5B | 417.2B | 374.4B | — | 364.4B |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 25.8B | 126.9B | 101.9B | — | 97.8B |
| General & Admin Expense | — | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 1.3B | 41.8B | 3.7B | — | 15.4B |
| Total Operating Expenses | 27.1B | 168.7B | 105.6B | — | 113.2B |
| Cost and Expenses | 333.0B | 333.0B | 281.7B | 281.8B | 277.7B |
| Operating Income (EBIT) | 166.7B | 166.7B | 156.6B | 153.3B | 149.0B |
| Non-Operating | |||||
| Interest Income | 13.6B | 80.8B | 53.2B | — | 75.8B |
| Interest Expense | 2.3B | 8.6B | 9.0B | — | 4.5B |
| Net Interest Income | 11.2B | 72.2B | 44.1B | — | 71.3B |
| Other Non-Op Income/Expense | 85.0M | 47.2B | 528.0M | — | 3.9B |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 46.3B | 238.9B | 200.8B | — | 220.3B |
| Income Tax Expense | 7.0B | 33.0B | 31.2B | — | 35.8B |
| Bottom Line | |||||
| Net Income | 205.2B | 205.2B | 170.4B | 162.0B | 185.0B |
| Earnings from Cont. Ops | — | — | — | — | — |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 205.9B | 205.9B | 169.5B | 160.6B | 184.5B |
| Per Share | |||||
| Basic EPS | ¥241 | ¥241 | ¥200 | ¥559 | ¥621 |
| Diluted EPS | ¥241 | ¥241 | ¥200 | ¥558 | ¥621 |
| Revenue Per Share | ¥587 | ¥587 | ¥515 | ¥1,500 | ¥1,433 |
| Shares | |||||
| Basic Shares Outstanding | 850.9M | 850.9M | 850.6M | 290.1M | 297.7M |
| Diluted Shares Outstanding | — | — | — | — | — |
| Profitability Metrics | |||||
| EBITDA | 40.1B | 193.7B | 177.5B | — | 166.2B |
| D&A | 5.0B | 27.0B | 20.9B | — | 17.2B |
| EBIT | 166.7B | 166.7B | 156.6B | 153.3B | 149.0B |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026